ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
0,00%
Bitcoin
63.434,00
-0,72%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Taiwan Liposome Company Ltd (TLC)

  7. Taiwan Liposome Company Ltd (TLC) News

TLC

Taiwan Liposome (TLC)

Taiwan Liposome Company Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TLC
DatumZeitQuelleÜberschriftSymbolFirma
20/11/202309h54GlobeNewswire Inc.Highlights of Dr. David Hunter’s Oral Presentation at ACR’s Late Breaking Abstracts SessionNASDAQ:TLCTaiwan Liposome Company Ltd
08/11/202310h54GlobeNewswire Inc.TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACRNASDAQ:TLCTaiwan Liposome Company Ltd
13/06/202212h30GlobeNewswire Inc.TLC Announces TLC599 Agreement with EndoNASDAQ:TLCTaiwan Liposome Company Ltd
07/03/202210h57GlobeNewswire Inc.TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & TherapyNASDAQ:TLCTaiwan Liposome Company Ltd
18/02/202222h04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TLCTaiwan Liposome Company Ltd
27/01/202212h13Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:TLCTaiwan Liposome Company Ltd
20/10/202122h09Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TLCTaiwan Liposome Company Ltd
15/10/202112h33Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
15/09/202122h02Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
15/09/202117h57Edgar (US Regulatory)Appointment of Agent for Service of Process and Undertaking (f-x)NASDAQ:TLCTaiwan Liposome Company Ltd
08/09/202122h11Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
08/09/202110h40GlobeNewswire Inc.TLC Announces Voluntary Delisting and Deregistration of American Depositary SharesNASDAQ:TLCTaiwan Liposome Company Ltd
26/08/202122h11Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
26/08/202122h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
24/08/202122h02Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
20/08/202122h08Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TLCTaiwan Liposome Company Ltd
12/08/202111h44GlobeNewswire Inc.TLC Reports Second Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:TLCTaiwan Liposome Company Ltd
06/08/202118h51Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
05/08/202120h38Edgar (US Regulatory)Tender Offer/rights Offering Notification (cb)NASDAQ:TLCTaiwan Liposome Company Ltd
04/08/202115h14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
22/07/202112h05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
07/07/202123h19Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
06/07/202112h44Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
05/07/202112h16GlobeNewswire Inc.TLC Announces Details of Stock Swap TransactionsNASDAQ:TLCTaiwan Liposome Company Ltd
26/05/202110h30GlobeNewswire Inc.TLC and Zydus Enter Agreement to Launch AmphoTLC™ in IndiaNASDAQ:TLCTaiwan Liposome Company Ltd
25/05/202111h05GlobeNewswire Inc.TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in IndiaNASDAQ:TLCTaiwan Liposome Company Ltd
23/05/202115h00GlobeNewswire Inc.InspirMed Highlights Encouraging Data on ISPM21 and ISPM19 – Inhalable Liposome Formulations of Antiviral Drugs for COVID-1...NASDAQ:TLCTaiwan Liposome Company Ltd
14/05/202113h32GlobeNewswire Inc.TLC Reports First Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:TLCTaiwan Liposome Company Ltd
14/05/202113h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
03/05/202111h15GlobeNewswire Inc.TLC Earns Highest Ranking in Corporate Governance Evaluation Seven Years RunningNASDAQ:TLCTaiwan Liposome Company Ltd
 Showing the most relevant articles for your search:NASDAQ:TLC

Kürzlich von Ihnen besucht

NASDAQ
NVDA
NVIDIA
TG
432
Arbor Metals
TG
BAS
BASF
TG
NOV
Novo Nordisk
AMEX
SPY
SPDR S&P 500
NASDAQ
GOOGL
Alphabet
AMEX
XLE
Energy Select Sector SPDR
TG
TUI1
Tui
DBI
TDXP
Tec DAX
NYSE
KO
Coca Cola
CCOM
US30
US 30
DBI
DAX
DAX
USOTC
BNPQY
BNP Paribas (QX)
COIN
BTCUSD
Bitcoin
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten